Breed Reply Invests in METRON and TAG Sensors
The two companies raised a total of £3.75 million from Breed Reply and other investors. These new investments mean Breed Reply’s pan-European investment portfolio of early stage IoT businesses has increased to 20 in a variety of different sectors, including health, industrial IoT, smart buildings and cities, and transportation.
METRON increases Breed Reply’s focus on industrial IoT technology. Energy is a significant cost in many industries and METRON’s technology provides industrial clients with an intelligent network that can better manage energy usage.
The technology provides the virtual mapping of the energy used in industrial processes and big data analytics to allow companies to be predictive and proactive in energy efficiency. By using artificial intelligence and control capabilities, METRON’s platform communicates directly with energy markets and decentralized energy assets to optimise operations in real-time according to context. Its customers include leading manufacturing companies from a variety of energy-intensive industries and METRON also partners with facility managers, utilities and OEMs in Europe, Latin America and the Middle-East.
TAG Sensors platform also offers significant benefits to customers, particularly in the pharmaceutical and food industries, including McDonald’s, where temperature control of goods is vital to ensure product quality. TAG Sensors has developed a market-leading technology using radio-frequency identification (RFID). For the first time, it is possible to have continuous real-time temperature logging of individual products required to be kept at specific temperatures such as food and vaccines. In the food industry, an estimated $813 billion is lost each year globally from poor cold-chain management and the pharmaceutical industry loses an estimated $12.5 billion per annum due to temperature fluctuations of products in shipping and storage.
Both METRON and TAG Sensors meet Breed Reply’s investment criteria of companies that combine strong management teams with an innovative technology that solves a real-world problem.
As well as funding, Breed Reply will work closely with management to accelerate both companies’ development to achieve Series A funding and beyond. Last year, one-third of Breed Reply’s portfolio raised more than $50 million of Series A funding.
The Breed Reply team has significant experience in scaling up early-stage businesses, in-depth understanding of different markets, proven track record in sales channel development and strong technological DNA. They also work closely with Reply Group, a leading consulting, systems integration and digital services company with a market presence all over Europe and the USA to help the investee companies commercialise their products.
Emanuele Angelidis, CEO of Breed Reply, said: “METRON and TAG Sensors are fantastic additions to our investment portfolio. As well as strong management, they have business ideas with long-term potential and technologies that companies are looking for. There is a considerable market for TAG Sensors low cost, versatile and highly-automated solution to the problem of cold-chain management and METRON’s ability to deliver improved energy efficiency to lower costs and meet ever stricter environmental regulations is vital for a multitude of industries. We are looking forward to supporting them to achieve their ambitions.”
Vincent Sciandra, CEO, METRON said: “This new funding will support the international growth of METRON and increase our ability to roll-out our highly successful energy intelligence platform. Over the last five years, we have helped companies across a variety of industries turn energy efficiency from a static, reactive process into a dynamic, proactive strategy. We are reshaping the way energy data is used. It is a strong endorsement of our technology and potential that Breed Reply has backed us and we look forward to working with them.”
Knut Nygard, CEO, TAG Sensors, said: “There is increasing global demand for our complete solution for cold chain management from leading companies in both the pharmaceutical and food industries. Major brands such as McDonald’s have tested and adopted our system in recent years and this new funding will enable us to expand and make our system available to more and more customers. The addition of Breed Reply as an investor, with its expertise in helping IoT companies scale-up and continued support of Platform Ventures will help us grow, invest more in innovation and seek opportunities in other sensor-based market segments.”
About Breed Reply
Breed Reply, Reply's active operational investor, funds and supports the development of early-stage companies in the Internet of Things (IoT) in Europe and the USA. Based in London, with operational offices in Germany and Italy, Breed Reply supports entrepreneurs and young talent by quickly bringing new ideas to the market. This is done via three fundamental services: funding at early-stage level; active operational involvement with significant know how transfer of business, managerial and technological expertise; and go-to-market support through the extensive Reply network. Breed Reply’s focus is the Internet of Things over all markets, with their current portfolio in Health, Fitness & Wellness, Smart Building & Cities, Security, Industrial IoT, Big Data, Platforms and Drones.www.breedreply.com
Founded in 2013, METRON has developed an energy intelligence platform to help industrial factories become energy transparent. By harnessing multiple sources of data generated by industrial systems, METRON Energy Virtual Assistant leverages latest machine learning capabilities and dedicated knowledge bases to proactively identify energy savings opportunities, connect to decentralised energy resources and turn energy into a profit centre. The company has more than 40 experts, data scientists and energy engineers, who help industrial clients in all sectors to maximise value from their energy data and support them with the implementation of energy efficiency optimisations.
About TAG Sensors
TAG Sensors is a complete cold-chain logistics solution for the food and pharmaceutical industries. It has developed the first low-cost, full visibility solution that ensures and proves that temperature sensitive foods and pharmaceutical products have been stored and transported within the temperature limits.
TAG Sensors radio-frequency identification (RFID) temperature logger label is the only one on the market that can effectively track temperature and other variables of an individual package from production to consumption, ensuring transparency, improving quality control and minimising wastage due to improper handling.
Redleaf Communications for Breed Reply
Robin Tozer / Ian Silvera
+44 (0)20 3757 6865
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Huawei Rewrites the Rules of Photography with Groundbreaking HUAWEI P30 Series26.3.2019 16:04:00 CET | Pressemelding
During an exclusive launch event today at the Paris Convention Center, Huawei Consumer Business Group (BG) unveiled the HUAWEI P30 and HUAWEI P30 Pro. The HUAWEI P30 Series builds on the HUAWEI P Series DNA in design and photography and is the company’s most advanced series of smartphone cameras. These devices feature the innovative HUAWEI SuperSpectrum Sensor, an optical SuperZoom Lens, a new HUAWEI Time of Flight (ToF) Camera, and enhanced optical and AI image stabilization technology. With these revolutionary technologies, the HUAWEI P30 and HUAWEI P30 Pro capture incredible photos and videos in every scenario. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005752/en/ HUAWEI P30 Series (Photo: Business Wire) Richard Yu, CEO of Huawei Consumer BG, said, “the HUAWEI P30 Series is a fundamental breakthrough after decades of digital camera technology development; it will rewrite the rules and reshape everyone’s percepti
Takeda Presents New Data at the Endocrine Society’s 2019 Annual Meeting about the Patient Burden and Long-Term Impact of Chronic Hypoparathyroidism26.3.2019 15:01:00 CET | Pressemelding
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) this week shared new data revealing the burden of chronic hypoparathyroidism on patients and caregivers, as well as potential long-term risks of renal and cardiovascular complications that patients treated with conventional therapy may experience. Six-year results from the open-label long-term safety and efficacy RACE study were also announced. Data was presented at the Endocrine Society’s 2019 Annual Meeting (ENDO) from 23–26 March in New Orleans, Louisiana, USA. “Results from the Burden of Illness Global Survey in 13 countries reveal the extent of the impact hypoparathyroidism has on patients and their caregivers throughout their daily lives,” said John Bilezikian M.D., Professor of Medicine at the Columbia University Irving Medical Center, New York, NY, USA. “This offers important insights and enables us to take a more holistic approach in the management of these patients due to a greater understanding of the poten
LEO Pharma Standardizes on Veeva Development Cloud to Speed Drug Development26.3.2019 14:58:00 CET | Pressemelding
Veeva Systems (NYSE:VEEV) today announced that LEO Pharma, a global leader in medical dermatology, selected Veeva Development Cloud applications to help drive end-to-end business processes across product development. The company will utilize the Vault Clinical, Vault RIM, and Vault Quality suites to unify drug development on a single cloud platform. With Veeva Development Cloud, LEO Pharma can bring together applications for clinical, regulatory, and quality for even greater efficiency and compliance throughout the product development lifecycle. “LEO Pharma R&D has embarked on an ambitious strategy for 2025, which will pave the way for our ambitions to continuously pioneer dermatology. This requires that we are able to drive science globally, whilst at the same time securing timely delivery on our pipeline,” said Kim Kjøller, executive vice president of global research and development at LEO Pharma. “Veeva Development Cloud gives us a unified platform that can enable us to maximize eff
Keio Plaza Hotel Tokyo Hosts Japanese Sword Culture, Armor Exhibition – “Japan’s Soul and Beauty of Swords and Armor by Legendary Artisans”26.3.2019 14:05:00 CET | Pressemelding
Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will host a special exhibition entitled “Japan’s Soul and Beauty of Swords and Armor by Legendary Artisans” displaying beautiful Japanese swords and armor from April 25 (Thursday) to June 27 (Thursday), 2019 in the 3rd floor lobby of our Hotel. This exhibition is part of our series of cultural programs designed to introduce various aspects of Japanese culture to our guests visiting the Hotel from over 100 different countries around the world. Various precious and old swords and armor made during the Heian Period (794-1185) and other periods of Japanese history will be displayed, along with “tsuba” (Sword handle guards separating the handle from the blade) and other ornate sword fittings. On May 14, two masters of sword-drawing from Ryushin Shouchi School will give a live performance in the Main lobby from 5:00 p.m. This press release features multimedia. View the full release
Andersen Global Enters Qatar26.3.2019 13:30:00 CET | Pressemelding
Andersen Global today announced a collaborating agreement in Qatar with Al-Khalifa Law, a leading Doha-based law firm. The collaboration is Andersen Global’s first in Qatar and is part of the organization’s continued growth in the Middle East. Al-Khalifa Law was founded 20 years ago and established itself as a premier firm in the region. The team at Al-Khalifa Law has diversified, deep experience providing services in a wide variety of business sectors, such as commercial contracts, taxation, employment, real estate and retail, intellectual property, dispute resolution and litigation and arbitration. “A collaboration with Andersen Global, which brings with it a culture of stewardship, transparency, and providing best-in-class services, was an obvious decision for us,” said Hamzeh Abdelhady, Office Managing Director of Al-Khalifa Law. “We will be able to continue providing quality services in the market and bring a premier, seamless association of experts throughout the world directly t
Vivior’s System Cleared for CE Mark – Market Introduction This Year in Europe26.3.2019 13:18:00 CET | Pressemelding
Vivior has cleared their system as a Class I medical device and is planning the market introduction later this year in Switzerland and the European Union. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005594/en/ The Visual Behavior Monitor (Photo: Business Wire) Vivior has notified Swissmedic about their product, the Visual Behavior Monitor, and fulfills all requirements for a medical device Class I according to the Medical Device Directive (MDD). With this important step, Vivior is now allowed to sell their system in Switzerland and the European Union. Mario Stark, CEO at Vivior, explains: “We are happy to be able to start market introduction and will, in a first step, work with selected clinics in Europe.” Prof. Michael Mrochen, Chairman of the Board of Directors, adds: “This constitutes an important milestone in the development of the Vivior system. We are now ready to support eye care professionals in offering the